Abstract
Background
The impact of different radiotherapy modalities on the development and characteristics of second primary bladder cancers (BCa) and BCa-specific mortality (BCa-SM) remains unclear. Thus, we evaluated the incidence and biological behavior of subsequent BCa and related survival in patients who underwent radiation therapy for prostate cancer (PCa).
Methods
A total of 530,581 patients in the surveillance, epidemiology, and end results database with localized PCa between 1988 and 2013 were identified. PCa treatments included radical prostatectomy (RP), external beam radiotherapy (EBRT), radioactive implants (RI), and combined EBRT and RI (EBRI). A multivariable competing risk analysis based on a proportional sub distribution hazards model was used to determine the impact of different radiotherapy modalities on BCa incidence and specific mortality.
Results
Incidence of BCa was significantly high in patients treated with EBRT, RI, and EBRI vs. RP [sub distribution hazard ratio (SHR) 1.41, P < 0.001; SHR 1.58, P < 0.001; SHR 1.56, P < 0.001, respectively]. BCa following EBRT, RI, and EBRI were more commonly non-urothelial (3.3%, 2.9%, 3.3%, respectively, versus 1.2%) and T4 (3.5%, 6.1%, 5.0%, respectively, versus 1.6%) compared with RP. RI associated with a higher rate of BCa metastasis than RP (2.6% vs. 1.1%). Prior EBRT, RI, and EBRI increased BCa-SM (SHR 1.44, P = 0.001; SHR 1.21, P = 0.047; and SHR 1.42, P = 0.032, respectively).
Conclusions
Patients receiving radiotherapy for PCa have a higher risk of BCa. BCa after EBRT, RI, and EBRI is more likely to be non-urothelial, stage T4, and with increased BCa-SM. Prior RI associated with a higher rate of BCa metastasis.
Similar content being viewed by others
References
Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424
Burger M, Catto JW, Dalbagni G et al (2013) Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63:234–241
Woudstra EC, Brunsting JF, Roesink JM et al (1996) Radiation induced DNA damage and damage repair in three human tumour cell lines. Mutat Res 362:51–59
Yamamoto S, Romanenko A, Wei M et al (1999) Specific p53 gene mutations in urinary bladder epithelium after the Chernobyl accident. Cancer Res 59:3606–3609
Preston D, Ron E, Tokuoka S et al (2007) Solid cancer incidence in atomic bomb survivors: 1958–1998. Radiat Res 168:1–64
Okeanov A, Sosnovskaya E, Priatkina O (2004) A national cancer registry to assess trends after the Chernobyl accident. Swiss Med Wkly 134:645–649
Romanenko AM, Kinoshita A, Wanibuchi H et al (2006) Involvement of ubiquitination and sumoylation in bladder lesions induced by persistent long-term low dose ionizing radiation in humans. J Urol 175:739–743
Alina R, Anna K, Keiichirou M et al (2009) Urinary bladder carcinogenesis induced by chronic exposure to persistent low-dose ionizing radiation after Chernobyl accident. Carcinogenesis 30:1821–1831
Mottet N, Bellmunt J, Bolla M et al (2017) EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 71:618–629. https://doi.org/10.1016/j.eururo.2016.08.003
Carroll PR, Parsons JK, Andriole G et al (2016) NCCN guidelines insights: prostate cancer early detection, version 2.2016. J Natl Compr Cancer Netw 14:509
Moschini M, Zaffuto E, Karakiewicz PI et al (2019) External beam radiotherapy increases the risk of bladder cancer when compared with radical prostatectomy in patients affected by prostate cancer: a population-based analysis. Eur Urol 75:319–328
Wallis CJ, Mahar AL, Choo R et al (2016) Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis. BMJ 352:i851
Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496–509
Davis EJ, Beebe-Dimmer JL, Yee CL et al (2015) Risk of second primary tumors in men diagnosed with prostate cancer: a population-based cohort study. Cancer 120:2735–2741
Wallis CJD, Mahar AL, Choo R et al (2016) Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis. Br Med J 352:i851
Sanath K (2012) Second malignant neoplasms following radiotherapy. Int J Environ Res Public Health 9:4744–4759
Hall EJ (2006) Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 65:1–7
Igor S, Sachs RK, Brenner DJ (2010) Cancer risks after radiation exposure in middle age. J Natl Cancer Inst 102:1628–1636
Bostrom PJ, Soloway MS, Manoharan M et al (2008) Bladder cancer after radiotherapy for prostate cancer: detailed analysis of pathological features and outcome after radical cystectomy. J Urol 179:91–95
Yee DS, Shariat SF, Lowrance WT et al (2010) Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer. J Urol 183:1751–1756
Essen CFV (1991) Radiation enhancement of metastasis: a review. Clin Exp Metastasis 9:77–104
Wright JL, Porter MP, Li CI et al (2006) Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder. Cancer 107:721–728
Fahed E, Hansel DE, Raghavan D et al (2012) Small cell bladder cancer: biology and management. Semin Oncol 39:615–618
Scosyrev E, Yao J, Messing E (2009) Urothelial carcinoma versus squamous cell carcinoma of bladder: is survival different with stage adjustment? Urology 73:822–827
Zaorsky NG, Churilla T, Egleston B et al (2016) Causes of death among cancer patients. Ann Oncol 28:400–407
Abern MR, Dude AM, Tsivian M et al (2013) The characteristics of bladder cancer after radiotherapy for prostate cancer. Urol Oncol 31:1628–1634. https://doi.org/10.1016/j.urolonc.2012.04.006
Rao MV, Chandy E, Timothy S et al (2013) Intravesical bacillus Calmette-Guerin immunotherapy after previous prostate radiotherapy for high-grade non-muscle-invasive bladder cancer. Urol Oncol 31:857–861
Rao MV, Quek ML, Jayram G et al (2013) Radical cystectomy after BCG immunotherapy for high-risk nonmuscle-invasive bladder cancer in patients with previous prostate radiotherapy. ISRN Urol 2013:405064–405064
Jayram G, Katz MH, Steinberg GD (2009) Radical cystectomy in patients previously treated for localized prostate cancer. J Urol 76:1430–1433
Eisenberg MS, Dorin RP, Bartsch G et al (2010) Early complications of cystectomy after high dose pelvic radiation. J Urol 184:2264–2269
Acknowledgements
We would like to thank the reviewers and the editor for the positive and constructive comments and suggestions.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors have declared no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Guo, X., Liu, M., Hou, H. et al. Impact of prostate cancer radiotherapy on the biological behavior and specific mortality of subsequent bladder cancer. Int J Clin Oncol 24, 957–965 (2019). https://doi.org/10.1007/s10147-019-01427-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-019-01427-9